Please register to receive the ZOOM meeting link:
Description: This presentation highlights radiopharmaceutical production and development resources available through the IUSM In-Vivo Imaging Core. The PET radiopharmaceuticals currently (or soon to be) available through Core resources and their application to disease management and therapeutic development in cardiology, neuroscience and oncology will be described. These include selective radiopharmaceuticals for non-invasive measurement of multiple metabolic processes (protein synthesis, lipid biosynthesis, oxidative metabolism, glutamine metabolism, blood flow/tissue perfusion), as well as binding to specific receptors and biomarkers. Additionally, opportunities for collaborative research efforts with faculty members in the Molecular Imaging Ligand Development Program (MILDP) of the IUSM Department of Radiology & Imaging Sciences will be presented. Such efforts include the development of novel PET radiopharmaceuticals and novel imaging methods using previously reported radio pharmaceuticals not currently available through the Core.
The Access Technology Program provides investigators access and guidance in using novel technologies and Core Services. Services and views presented belong solely to the vendor; they do not necessarily reflect the views of the Indiana CTSI, Indiana University, Purdue University or University of Notre Dame.